South Korea’s Supreme Court affirmed a lower court’s verdict to fine Kookmin Card, Lotte Card, and NongHyup Card between 10 million and 15 million won each for mishandling customer data.
The companies were found violating the Personal Information Protection Act by allowing subcontractors free access to customers’ information from 2012 to 2013.
NongHyup Card and Kookmin Card were each responsible for over 40 million customer data breaches in 2012, while Lotte Card had nearly 20 million data leaked in 2013.
The leaked data includes customers’ names, credit card numbers, phone numbers, and identification numbers.
Subcontractors, who illegally accessed the companies’ systems, sold the stolen data to loan brokers.
At the first trial in 2016, the Seoul Central District Court imposed the highest penalty on the companies.
The credit card companies' appeal was dismissed by the appellate court in March this year.
A fine of 10 million won is imposed on companies that mismanage personal data. The fine can go up to 15 million won if the breach is repeated.


Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Anta Sports Expands Global Footprint With Strategic Puma Stake
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil 



